close 74% jaeinvestorite kontodest jääb selle teenusepakkuja juures hinnavahelepingutega kauplemisel kahjumisse. Investeerimisega kaasnevad riskid ja need ei ole sobilikud kõigile investoritele. CFD-d on keerukad instrumendid, millega kaasneb võimenduse tõttu suur risk kaotada raha kiiresti. 74% jaeinvestorite kontodest jääb selle teenusepakkuja juures CFD-dega kauplemisel kahjumisse. Palume teil kaaluda, kas CFD-de toimimine on teile arusaadav ja kas te olete valmis võtma riski, mis suure tõenäosusega on kahjumlik.
Change languageEesti
Ülevaade

LLY

754.57

-0.24%↓

JNJ

178.08

-0.17%↓

ABBV

218.3

-0.8%↓

UNH

352.9

-0.29%↓

AZN

79.54

-1.96%↓

LLY

754.57

-0.24%↓

JNJ

178.08

-0.17%↓

ABBV

218.3

-0.8%↓

UNH

352.9

-0.29%↓

AZN

79.54

-1.96%↓

LLY

754.57

-0.24%↓

JNJ

178.08

-0.17%↓

ABBV

218.3

-0.8%↓

UNH

352.9

-0.29%↓

AZN

79.54

-1.96%↓

LLY

754.57

-0.24%↓

JNJ

178.08

-0.17%↓

ABBV

218.3

-0.8%↓

UNH

352.9

-0.29%↓

AZN

79.54

-1.96%↓

LLY

754.57

-0.24%↓

JNJ

178.08

-0.17%↓

ABBV

218.3

-0.8%↓

UNH

352.9

-0.29%↓

AZN

79.54

-1.96%↓

Kodu・Aktsiate loetelu・Nektar Therapeutics
Search

Nektar Therapeutics

Suletud

48.31 2.2

Osta

Hinna uuendus 12. sept 2025, 19:59 UTC

OstaMüü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

47

Max

48.51

Põhinäitajad

By Trading Economics

Sissetulek

9.3M

-42M

Müük

715K

11M

Aktsiakasum

-2.78

Kasumimarginaal

-372.197

Töötajad

61

EBITDA

4.7M

-36M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+93.92% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

6. nov 2025

Turustatistika

By TradingEconomics

Turukapital

439M

843M

Eelmine avamishind

46.11

Eelmine sulgemishind

48.31

Tehniline skoor

By Trading Central

Kindlus

Strong Bearish Evidence

0.5949 / 0.7406 Toetus ja vastupanu

Nektar Therapeutics Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

12. sept 2025, 22:41 UTC

Suurimad hinnamuutused turgudel

GlucoTrack Stock Falls on Plans to Sell $3 Million Note

DJ

Loe

12. sept 2025, 16:04 UTC

Suurimad hinnamuutused turgudel

Upexi Shares Climb on Solana Gains

DJ

Loe

12. sept 2025, 15:03 UTC

Suurimad hinnamuutused turgudel

Allied Gaming & Entertainment Shares Surge Following Crypto Investments

DJ

Loe

13. sept 2025, 08:20 UTC

Market Talk
Tulu

Tech, Media & Telecom Roundup: Market Talk

DJ

Loe

12. sept 2025, 20:50 UTC

Market Talk
Tulu

Tech, Media & Telecom Roundup: Market Talk

DJ

Loe

12. sept 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

DJ

Loe

12. sept 2025, 20:09 UTC

Tulu

Correction to Opendoor Is Sliding. Don't Call It a Meme Stock, Says New Chairman. -- Barrons.com

DJ

Loe

12. sept 2025, 19:23 UTC

Market Talk

Oil Futures End Volatile Week With Moderate Gains -- Market Talk

DJ

Loe

12. sept 2025, 19:16 UTC

Market Talk

Oil Futures End Volatile Week With Moderate Gains -- Market Talk

DJ

Loe

12. sept 2025, 19:03 UTC

Market Talk

Natural Gas Futures Held Back By Plump Inventories -- Market Talk

DJ

Loe

12. sept 2025, 18:59 UTC

Market Talk

Dollar Pares Gains as Economy Keeps Showing Signs of Cooling -- Market Talk

DJ

Loe

12. sept 2025, 18:38 UTC

Market Talk
Tulu

Adobe Seen Reaching Turning Point in AI Cycle -- Market Talk

DJ

Loe

12. sept 2025, 18:33 UTC

Market Talk

U.S. Oil Rig Count Rises By 2 to 416 -- Market Talk

DJ

Loe

12. sept 2025, 18:22 UTC

Market Talk

Canada's Divergence With US On Capex Spending is 'Appalling' -- Market Talk

DJ

Loe

12. sept 2025, 16:56 UTC

Market Talk

Renewable Fuels Association Calls for Nationwide E15 Following WASDE -- Market Talk

DJ

Loe

12. sept 2025, 16:22 UTC

Tulu

Adobe Earnings Were 'Solid.' Long-Term Growth Concerns Remain. -- Barrons.com

DJ

Loe

12. sept 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

DJ

Loe

12. sept 2025, 16:19 UTC

Omandamised, ülevõtmised, äriostud

These Stocks Are Moving the Most Today: Warner Bros., Paramount Skydance, Tesla, Super Micro, Microsoft, Figure Technology, and More -- Barrons.com

DJ

Loe

12. sept 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

DJ

Loe

12. sept 2025, 16:11 UTC

Tulu

Novartis Catches a 'Sell.' Goldman Sachs Says the Stock Is Overvalued. -- Barrons.com

DJ

Loe

12. sept 2025, 15:37 UTC

Market Talk

Gold Holds Near All-Time Highs Ahead of Fed Meeting Next Week -- Market Talk

DJ

Loe

12. sept 2025, 15:22 UTC

Market Talk

European Gas Lifted by Geopolitical Risks But Storage Levels Ease Supply Fears -- Market Talk

DJ

Loe

12. sept 2025, 15:07 UTC

Omandamised, ülevõtmised, äriostud

These Stocks Are Moving the Most Today: Warner Bros., Paramount Skydance, Tesla, Super Micro, Microsoft, Figure Technology, and More -- Barrons.com

DJ

Loe

12. sept 2025, 14:34 UTC

Market Talk

Russia Sanctions Put Bid Back in Oil -- Market Talk

DJ

Loe

12. sept 2025, 14:10 UTC

Market Talk

Inflation Report Unlikely to Dissuade Canada From Rate Cut -- Market Talk

DJ

Loe

12. sept 2025, 13:58 UTC

Market Talk

Dollar Could Rise if Fed Sounds Cautious on Rate Cuts -- Market Talk

DJ

Loe

12. sept 2025, 13:58 UTC

Omandamised, ülevõtmised, äriostud

These Stocks Are Moving the Most Today: Warner Bros., Paramount Skydance, Super Micro, Adobe, Microsoft, Figure Technology, and More -- Barrons.com

DJ

Loe

12. sept 2025, 13:57 UTC

Tulu

AbbVie Stock Hit a Record on 'Big Win' for Blockbuster Drug. The Case for Buying In. -- Barrons.com

DJ

Loe

12. sept 2025, 13:56 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

DJ

Loe

12. sept 2025, 13:56 UTC

Market Talk

Canadian Dollar Faces Further Weakness Vs Non-U.S. Dollar Currencies -- Market Talk

DJ

Loe

Võrdlus sarnastega

Hinnamuutus

Nektar Therapeutics Prognoos

Hinnasiht

By TipRanks

93.92% tõus

12 kuu keskmine prognoos

Keskmine 94.4 USD  93.92%

Kõrge 120 USD

Madal 69 USD

Põhineb 8 Wall Streeti analüütiku instrumendi Nektar Therapeutics 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

8 ratings

6

Osta

1

Hoia

1

Müü

Põhineb 8 analüütiku instrumendi Nektar Therapeutics aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

0.5949 / 0.7406Toetus ja vastupanu

Lühikene perspektiiv

Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Keskpikk perspektiiv

Strong Bearish Evidence

All events are bearish.

Pikk perspektiiv

Bearish Evidence

All events are bearish.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Muud aktsiad sektorist

LLY

Eli Lilly and Co.

754.57

↓-0.24%

JNJ

Johnson and Johnson

178.08

↓-0.17%

ABBV

AbbVie Inc

218.3

↓-0.8%

UNH

UnitedHealth Group Inc

352.9

↓-0.29%

AZN

AstraZeneca PLC ADR

79.54

↓-1.96%
help-icon Live chat